Merck, GE17-0210-01, CM-Sephadex®C-25

General description
CM Sephadex® A-25 is a weak cation exchanger based on the well documented and well proven Sephadex® base matrix.
lgG (Mr 160 000)- 1.6 mg/ml drained medium), Bovine COHb (Mr 69 000)- 70 mg/ml drained medium), Ribonuclease (Mr 13 700)- 190 mg/ml drained medium)
Application
Sephadex® ion exchangers are produced by introducing functional groups onto the cross-linked Dextran matrix. These groups are attached to glucose units in the matrix by stable ether linkages.

Different types of ion exchangers (DEAE, QAE and CM) and two different porosities (A-25/C-25 and A-50/C-50) are available.
Features and Benefits
Weak cation exchanger suitable batch techniques.
High binding capacities.

Preparation Note
Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
Store at 4 to 30 °C (4 to 8, Used Media 20% Ehtanol or 0.01 M NaOH)
Analysis Note
To view the Certificate of Analysis for this product, please visit www.cytiva.com.
Legal Information
Sephadex is a registered trademark of Cytiva